TABLE 1.
Correlation between clinicopathologic characteristics and BCAS3 expression
| Variables | NO. of patients | Nuclear BCAS3 level | P‐value | |
|---|---|---|---|---|
| BCAS3low (%) | BCAS3high (%) | |||
| Total cases | 140 | 69 (49.3) | 71 (50.7) | |
| Age (y) | ||||
| ≥55 | 82 | 41 (50.0) | 41 (50.0) | 0.865 |
| <55 | 58 | 28 (48.3) | 30 (51.7) | |
| Location | ||||
| Left | 62 | 26 (41.9) | 36 (58.1) | 0.13 |
| Right | 78 | 43 (55.1) | 35 (44.9) | |
| Tumour size (cm) | ||||
| D ≤ 3.3 | 82 | 49 (59.8) | 33 (40.2) | 0.004 |
| D > 3.3 | 58 | 20 (34.5) | 38 (65.5) | |
| Oestrogen receptor | ||||
| Positive | 83 | 43 (51.8) | 40 (48.2) | 0.496 |
| Negative | 57 | 26 (45.6) | 31 (54.4) | |
| Progesterone receptor | ||||
| Positive | 56 | 33 (58.9) | 23 (41.1) | 0.084 |
| Negative | 84 | 36 (42.9) | 48 (57.1) | |
| HER2 | ||||
| Positive | 134 | 66 (49.3) | 68 (50.7) | 0.646 |
| Negative | 6 | 3(86.5) | 3 (13.5) | |
| Histological grade | ||||
| Ⅱ | 69 | 43 (62.3) | 26 (37.7) | 0.004 |
| Ⅲ | 71 | 26 (36.6) | 45 (63.4) | |
| TNM stage | ||||
| Ⅰ | 21 | 17 (81.0) | 4 (19.0) | <0.001 |
| Ⅱ | 79 | 41 (51.9) | 38 (48.1) | |
| Ⅲ | 39 | 11 (28.2) | 28 (71.8) | |
P < 0.05 was considered statistically significant. Pearson's chi‐square test was used.